That is the title of the podcast episode I was on for AJMC’s Managed Care Cast. We discuss my recently published paper on insurance value in Duchenne’s Muscular Dystrophy (DMD). To learn more about research in DMD, check out AJMC’s DMD compendia page. The full podcast is below.
Similar Posts
How To Get Rid Of Moderate Depression Naturally?
Depression is a common and serious mental disorder that affects a lot of people around the…
FDA Approves Moderna RSV Vaccine, an mRNA Alternative to GSK and Pfizer Products – MedCity News
Moderna’s messenger RNA vaccine for respiratory syncytial virus (RSV) is now FDA approved, a regulatory decision…
These 3 Things Must Change for Hospital Cybersecurity to Improve – MedCity News
Cybercriminals across the globe continue to target healthcare organizations, exploiting any vulnerability they can. Healthcare entities…
FDA Approves Sarepta Gene Therapy, But Only After Top FDA Official Bucks Agency Staff – MedCity News
A Sarepta Therapeutics gene therapy that failed its confirmatory test has now converted its accelerated FDA…
FDA Flexibility Leads to First Approved Gene Therapy for Rare Blood & Immune System Disorder
A genetic disorder that leads to bleeding episodes and life-threatening infections has a new FDA approved…
12 Probiotic Foods for a Healthier Gut
September 25, 2023 Read moreThe Best Natural Skincare Products for Women Over 40 | Brenda Janschek…
